Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients – A Czech multicenter experienceSARS-CoV-2에 감염된 혈액학적 환자에서 항-SARS-CoV-2 단일클론 중화 항체의 성공적인 조기 사용 - 체코의 다기관 경험Multicenter Study Published on 2022-04-012022-09-12 Journal: Hematological oncology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] administration analyzed anti-CD20 anti-SARS-CoV-2 anti-SARS-CoV-2 monoclonal neutralizing antibodies Asymptomatic asymptomatic patient bamlanivimab baseline Casirivimab Cohort Combination Course COVID-19 COVID-19 diagnosis COVID-19 mortality COVID-19 symptom Critical death diagnose diagnosed early administration early-stage COVID-19 Efficacy evaluated Final first COVID-19 symptom Follow-up General population hematological Hematological malignancy imdevimab. impair Infection leukemia leukemias lymphoma lymphomas median Mild moderate monoclonal monoclonal antibody monotherapy Mortality multicenter multicentre Neutralizing neutralizing antibody neutralizing monoclonal antibody nine occurred Patient patients plasma positive remained Result SARS-CoV-2 significantly significantly lower Spike protein survival rate therapy treated were recorded [DOI] 10.1002/hon.2974 PMC 바로가기 [Article Type] Multicenter Study
Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, IranResearch article Published on 2021-08-012022-10-05 Journal: Seminars in oncology [Category] SARS, 진단, 치료법, [키워드] Affect antibodies Asymptomatic Brain Cancer cancer treatment center conducted coronavirus COVID-19 COVID-19 pandemic COVID-19 symptom diagnosing Diagnosis Diagnostic Criteria eight enrolled FIVE Hospitalized IgG and IgM Immunosuppressed Inpatient Iran leukemias Mild molecular nine oncology patient outcome Outpatient Patient patients patients died pediatric Pediatric patient pediatrics positive Research SARS-COV-2 infection SARS-CoV-2 infections Seven study period Tehran tested Treatment tumors with COVID-19 [DOI] 10.1053/j.seminoncol.2021.09.003 [Article Type] Research article
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)COVID19 및 소아 및 청소년의 급성 림프모구성 백혈병: 소아 및 청소년의 암 및 백혈병 퇴치를 위한 프랑스 학회(SFCE) 백혈병 위원회의 업데이트된 권장 사항(버전 2)Review Published on 2021-05-012022-09-11 Journal: Bulletin du cancer [Category] 치료제, [키워드] Acute lymphoblastic leukemia adolescents cancers children Committee COVID COVID 19 COVID19 Evolution French Infection knowledge leukemia leukemias Lymphoblastic leukemia recommendation recommendations SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2. Society the SARS-CoV-2 Treatment Version [DOI] 10.1016/j.bulcan.2021.02.004 PMC 바로가기 [Article Type] Review